Cancer Biology and the Principles of Targeted Cancer Drug Discovery

作者: P. Hillmann , D. Schmitz , J. Mestan , S. D’Alonzo , D. Fabbro

DOI: 10.1016/B978-0-12-409547-2.12390-X

关键词:

摘要: The understanding of molecular mechanisms cancer biology has greatly increased over the past decade. Additional hallmarks cancer, such as immune tolerance and deregulation cellular energetics, have been recognized. Targeted therapy aims to interfere with every hallmark cancer. Potential novel targets are constantly being identified evaluated. Novel therapeutics that efficacious in a subset tumors on their way clinic. Biomarker strategies for patient stratification evaluation benefit critical efficient use these personalized medicines. This article gives an overview different fields targeted drug discovery validate biomarkers.

参考文章(431)
Ron S. Ronimus, Nicholas C. Lloyd, Hugh W. Morgan, Brian K. Nicholson, Steven Riethmiller, SALVARSAN - THE FIRST CHEMOTHERAPEUTIC COMPOUND Ancat Holdings Ltd. ,vol. 69, pp. 24- 27 ,(2005)
D. Fabbro, G. Fendrich, V. Guez, T. Meyer, P. Furet, J. Mestan, J. D. Griffin, P. W. Manley, S. W. Cowan-Jacob, Targeted Therapy with Imatinib: An Exception or a Rule? Inhibitors of Protein Kinases and Protein Phosphates. ,vol. 167, pp. 361- 389 ,(2005) , 10.1007/3-540-26670-4_13
Fiorentina Ascenzioni, Piera Fradiani, Daniela Willems, Francesca Tilesi, Valentina Socci, Design and validation of siRNAs and shRNAs. Current Opinion in Molecular Therapeutics. ,vol. 11, pp. 156- 164 ,(2009)
Kimberly Cornish Carmony, Kyung-Bo Kim, PROTAC-Induced Proteolytic Targeting Methods of Molecular Biology. ,vol. 832, pp. 627- 638 ,(2012) , 10.1007/978-1-61779-474-2_44
David E. Gerber, Targeted therapies: a new generation of cancer treatments. American Family Physician. ,vol. 77, pp. 311- 319 ,(2008)
Antonio Jimeno, Rodabe N Amaria, T. Medina, Dabrafenib in the treatment of advanced melanoma. Drugs of Today. ,vol. 49, pp. 377- 385 ,(2013) , 10.1358/DOT.2013.49.6.1968669
Doriano Fabbro, Sandra W. Cowan-Jacob, Henrik Möbitz, Georg Martiny-Baron, Targeting cancer with small-molecular-weight kinase inhibitors. Methods of Molecular Biology. ,vol. 795, pp. 1- 34 ,(2012) , 10.1007/978-1-61779-337-0_1
Georgina N. Masoud, Wei Li, HIF-1α pathway: role, regulation and intervention for cancer therapy Acta Pharmaceutica Sinica B. ,vol. 5, pp. 378- 389 ,(2015) , 10.1016/J.APSB.2015.05.007
Agnes Görlach, Elitsa Y. Dimova, Andreas Petry, Antonio Martínez-Ruiz, Pablo Hernansanz-Agustín, Anabela P. Rolo, Carlos M. Palmeira, Thomas Kietzmann, Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? Redox biology. ,vol. 6, pp. 372- 385 ,(2015) , 10.1016/J.REDOX.2015.08.016